# Effect of Compound (Cardiol Forte) on Lipid And Glycemic Parameters in Low Cardiovascular Risk Individuals

> **NCT07515573** · NA · NOT_YET_RECRUITING · sponsor: **U.G.A. Nutraceuticals** · enrollment: 50 (estimated)

## Conditions studied

- Dyslipidemia

## Interventions

- **DIETARY_SUPPLEMENT:** Cardiol Forte
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07515573
- **Lead sponsor:** U.G.A. Nutraceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-04
- **Primary completion:** 2028-05-04
- **Final completion:** 2028-05-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07515573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07515573, "Effect of Compound (Cardiol Forte) on Lipid And Glycemic Parameters in Low Cardiovascular Risk Individuals". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07515573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*